Search Results

Pharm Country

Orbis International and NIDEK Join Forces to Scale Up Artificial Intelligence Eye Screenings in Vietnam

Orbis International announces an important in-kind and financial donation from NIDEK to support Orbis’s artificial intelligence -based screening services in Vietnam.

January 16, 2024

·

4 min read

Press Releases

Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles

January 6, 2025

·

3 min read

Business

Orbis International Teams Up with the Alcon Foundation and OMEGA to Improve Eye Care in Zambia

Global eye care nonprofit, Orbis International, is kicking off a surgical training program in Zambia on board the Orbis Flying Eye Hospital - the world’s only fully accredited ophthalmic teaching hospital on board a plane.

September 25, 2023

·

7 min read

Policy

Agitated Solutions Receives Health Canada License for Orbis Microbubble Generator to Streamline Cardiac Bubble Studies

Agitated Solutions, Incorporated announced that it has been issued a Medical Device Establishment License from Health Canada for its innovative Orbis™ Microbubble Generator that simplifies and streamlines the process of saline agitation and delivery for cardiac bubble studies.

April 18, 2024

·

3 min read

Pictured: Wall sign of the Novo Nordisk Foundation and Novo Holdings in Denmark

Business

Novo Holdings, Forbion Lead Financing for Orbis Medicine’s $28M Seed Round

Denmark-based startup Orbis Medicines has launched with €26 million in seed funding in its drive to search for macrocycle drugs, with a focus on high-value oral alternatives to blockbuster biologics.

February 29, 2024

·

2 min read

·

Tyler Patchen

Orbis Medicines Launches with €26 Million Seed Financing to Transform Macrocycle Drug Development through Next-Generation Orally Dosable ‘nCycles’

Orbis Medicines, a leader in oral macrocycle drug discovery, announces its launch with a €26 million financing led by global life sciences investor Novo Holdings and European life sciences venture firm Forbion.

February 29, 2024

·

6 min read

Symbol of money dollar from colored pills and capsules on green background. Expensive medicine and medical insurance

Venture Capitalists

Novo-Backed Oral Medicine Biotech Adds Lilly to Investors in $93M Series A

Orbis emerged from stealth in February 2024 with $28.1 million in seed funding. The Danish biotech, which aims to flip biologics into oral medicines, has now raised another $93 million.

January 6, 2025

·

1 min read

·

Annalee Armstrong

Press Releases

Jabil Acquires Pharmaceutics International, Inc. (Pii)

February 4, 2025

·

4 min read

Biotech Bay

Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion